Prof. Ray-Coquard obtained her medical degree in 1997 specializing in oncology. In 2003 she received her PhD from the Université Claude Bernard for her research on the independents factors that determine medical practices in oncology. She also received Master’s degrees in in statistics in 1995 and in medical economy in 1996. From 2008 to 2013, she has served as Chairman of the gynaecologic group for clinical trials of the French National Cancer Institute (INCA) and she is currently the Network Director of the national network dedicated to diagnosis and management of the rare gynecological cancer (www.ovaire-rare.org), a network funded by the INCA commission. At the Groupe d’investigateurs national evaluation des cancers de l’ovaire (GINECO), she has been active in the translational research advisory committee, the scientific committee, and as a chairman of endometrial cancer subgroup and the rare tumors committee. Since 2002, she is also developing translational research dedicated to ovarian cancer with the INSERM within the CRCL directed by A Puisieux within the CLB campus, and more directly with the research on rare gyn cancer biology (Carcinosarcoma, Granulosa cell tumors). From 2009 to 2018, she was the chairman of the rare cancer working group from GCIG (gynaecological cancer intergroup) dedicated to clinical trials in the field of all rare gynaecological cancers. She is president of the GINECO group since 2019. Member of the ESGO council since 2021 and Chair of the Gynecological track for ESMO since 2021. She is an active member of a number of professional groups, including the American Society of Clinical Oncology, the Connective Tissue Oncology Society, the French Society of Cancer, the European Association of Cancer Research, the EORTC organisation and the European Society for Medical Oncology (ESMO) and the European Society of Gynaecological Oncology (ESGO).